FACULTY AFFILIATIONS
 |
Lisa Carey, MD
Associate Professor
Hematology and Oncology Clinical
Research Program
UNC Lineberger Comprehensive Cancer Center
Chapel Hill, North Carolina |
 |
Jenny C Chang, MD
Associate Professor
Breast Center at
Baylor College of Medicine
Houston, Texas |
 |
Generosa Grana, MD
Associate Professor of Medicine
UMDNJ/Robert Wood Johnson
School of Medicine
Director, Breast Cancer Program
Cooper Hospital
Camden, New Jersey |
|
|
CONTENT VALIDATION AND DISCLOSURES
Postgraduate Institute for Medicine (PIM) assesses conflict of interest with its instructors, planners, managers and
other individuals who are in a position to control the content of CNE activities. All relevant conflicts of interest that
are identified are thoroughly vetted by PIM for fair balance, scientific objectivity of studies utilized in this activity
and patient care recommendations. PIM is committed to providing its learners with high-quality CNE activities
and related materials that promote improvements or quality in healthcare and not a specific proprietary business
interest of a commercial interest.
The faculty reported the following financial relationships or relationships to products or devices they or their
spouse/life partner have with commercial interests related to the content of this CNE activity:
Dr Carey — Consulting Fees: Genentech Inc, GlaxoSmithKline; Fees for Non-CME Services Received Directly from a
Commercial Interest or Their Agents: Genentech Inc; Contracted Research: Bristol-Myers Squibb Company, Genentech Inc,
GlaxoSmithKline. Dr Grana — Fees for Non-CME Services Received Directly from a Commercial Interest or Their Agents: AstraZeneca Pharmaceuticals LP, Genentech Inc, Novartis Pharmaceuticals Corporation, Sanofi-Aventis; Contracted Research: AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Company, Genentech Inc, GlaxoSmithKline. Dr Chang — Contracted
Research: AstraZeneca Pharmaceuticals LP, Genentech Inc, GlaxoSmithKline, Sanofi-Aventis.
The planners and managers reported the following financial relationships or relationships to products or devices
they or their spouse/life partner have with commercial interests related to the content of this CNE activity:
John H Brebner, Richard Kaderman, PhD, Neil Love, MD, Douglas Paley, Margaret Peng, Lilliam Sklaver Poltorack,
PharmD, Ginelle Suarez, Erin Wall and Kathryn Ault Ziel, PhD — no real or apparent conflicts of interest to report;
Sally Bogert, RNC, WHCNP — shareholder of Amgen Inc and Genentech Inc. Research To Practice receives
education grants from Abraxis Oncology, Amgen Inc, AstraZeneca Pharmaceuticals LP, Bayer Pharmaceuticals
Corporation/Onyx Pharmaceuticals Inc, Genentech Inc/OSI Pharmaceuticals Inc, Genomic Health Inc, Roche
Laboratories Inc and Sanofi-Aventis, who have no influence on the content development of our educational
activities.
The following PIM clinical content reviewers, Jan Hixon, RN; Linda Graham, RN; and Trace Hutchison, PharmD,
state that they or their spouse/life partner do not have any financial relationships or relationships to products or
devices with any commercial interests related to the content of this CNE activity of any amount during the past
12 months.
This educational activity may contain discussion of published and/or investigational uses of agents that are
not indicated by the FDA. Postgraduate Institute for Medicine (PIM), Research To Practice, Abraxis Oncology,
AstraZeneca Pharmaceuticals LP, Genentech Inc and Genomic Health Inc do not recommend the use of any agent
outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent
the views of PIM, Research To Practice, Abraxis Oncology, AstraZeneca Pharmaceuticals LP, Genentech Inc or
Genomic Health Inc. Please refer to the official prescribing information for each product for discussion of approved
indications, contraindications and warnings.
